Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
GLS4 with Ritonavir and Entecavir vs Entecavir in HBeAg+ Chronic HBV
NCT04147208Phase 2Completed
- Sponsor
- Sunshine Lake Pharma
- Start
- Feb 2019
- Primary completion
- Jun 2022
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of mofesertib in Chronic Hepatitis B (CHB), sponsored by Sunshine Lake Pharma. Started Feb 2019; status: completed.
02
Drugs
mofesertib
03
Conditions
Chronic Hepatitis B (CHB)
Beyond the preview
Go deeper on NCT04147208.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04147208.